source
- CNS players discuss deals, psychiatry challenges and Alzheimer focus at Jefferies London conferenceThe Jefferies Global Healthcare conference in London brought together several companies active in the central nervous system and psychiatry sectors. Attendees heard updates from a range of drugmake…
- FDA faces push for flexible rare-disease trial designs as commissioner's nomination withdrawnThe FDA’s weekly briefing highlighted several notable developments, including the sudden withdrawal of the Trump administration’s nominee for FDA commissioner at the last minute. The agency also a…